batirtze-areitio Batirtze Areitio Batirtze has over 5 years of experience in the biopharma and biotech industries. She joined ApexOnco in 2025 after working as an analyst at OncologyPipeline. She is a graduate of the University of Navarra, where she earned a degree in biochemistry. ESMO 2025 – Merck and Daiichi Rejoice over raludotatug 20 October 2025 ESMO 2025 – Merck shoots for an ovarian cancer first 19 October 2025 ESMO 2025 – iza-bren’s US backing comes with toxicity 18 October 2025 Junshi makes an early move with its VEGF bispecific 17 October 2025 Roche joins the CDH17 party 17 October 2025 Merck widens its TROP2 ambitions 16 October 2025 Boehringer’s latest conjugate deal rings some old bells 16 October 2025 Few pancreatic Gleams of hope for Vyloy 15 October 2025 Load More